Iranian company develops analytical blood sugar scan with Freesens BS test device

A groundbreaking advancement in diabetes management has emerged in Iran thanks to a female entrepreneur. 

Farir Asa Teb Company, under the woman’s management, has successfully developed the Freesens blood glucose testing device, which incorporates analytical scanning technology for the first time in the country. 

This innovative device allows physicians to access detailed analytical reports, enabling them to devise more effective treatment plans for patients. 

Founded in 2006, Farir Asa Teb specializes in diabetes management and has previously introduced reputable brands like GLUCOCARD 01 and CONTOUR PLUS. 

The Freesens device stands out due to its ability to measure blood glucose levels accurately, even under challenging conditions such as hand tremors or insufficient blood volume. 

Key features of the Freesens include direct data transfer to mobile devices via an app, the capability to store up to 880 test results, and comprehensive analytical reports that enhance patient and physician understanding of glucose fluctuations. 

This technology aims to improve diabetes control by providing precise data, which is crucial since traditional patient-reported glucose levels can often be inaccurate. 

The Freesens device represents a significant step forward in empowering both patients and healthcare providers in managing diabetes effectively.